Kremedine Health is an innovative approach of science & technologies to manufacture high standard drugs.
Kremedine was established on 17 November 2015. The age of the company is 6 years, 9 months.
A team of well qualified 50 people is associated with Kremedine Health.
The company holds capacity of producing 1,90,00,000 vial of injections annually.
We have major products of our company like - Cisplatin Inj., Vincristine Inj., Docetaxel Inj., Irinotecan inj., Gemcitabine Inj., Etoposide Inj. Carbaplatin Inj., Cabazitaxel inj., Paclitaxel Inj.
Kremedine health’s main market is in India and Nepal. Our products are also now going to get launched globally soon. Collaborations between pharmaceutical companies have varying focuses ranging from drug discovery and development to clinical trials and imaging etc.
1. Ensured quality standards, facilities and equipments.
2. We also provide collaborated trainings and advanced qualifications of our staff.
3. The company invests in new technologies & partnerships to push the boundaries of cancer research.
4. We strive to collaborate on targeting local market of India to meet our patient’s needs.
5. Our supply chain team makes sure to provide prompt services.
6. Company always takes care of needs of the team also providing flexible working hours with diversity in hiring staff.